Innovus Pharma Revenue, Profits - INNV Annual Income Statement

Add to My Stocks
$0.12 $0 (0%) INNV stock closing price Sep 18, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Innovus Pharma stock price alone is not sufficient. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $8.81M for 2017 impacts the INNV stock. Investors typically check year over year or quarter over quarter revenue growth. Along with Innovus Pharma assets and Innovus Pharma free cash flow, Innovus Pharma profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $-6.5M and the 2017 revenue is $8.81M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec20172016201520142013201220112010
Innovus Pharma Revenues or Net Sales
8.81M4.81M-1.03M----
Cost Of Goods Sold (COGS)1.84M1.08M------
Innovus Pharma Gross Profit
6.96M3.73M------
Research & Development Expense--------
Selling General & Admin Expense12.02M9.49M4.66M4.37M3.8M-2.12M-
Income Before Depreciation Depletion Amortization-5.09M-5.83M-4.27M-3.78M-3.88M-0.21M-2.18M-0.05M
Depreciation Depletion Amortization--------
Non Operating Income-0.52M-1.2M--0.51M----
Interest Expense-6.66M1.15M-----
Innovus Pharma Pretax Income
-6.5M-13.69M-4.95M-4.82M-3.95M-0.23M-2.25M-0.06M
Provision for Income Taxes---0.75M-----
MinorityInterest--------
Investment Gains Losses--------
Other Income--------
Income Before Extraordinaries & Disc Operations-6.5M-13.7M-4.2M-4.82M-3.95M-0.23M-2.25M-0.06M
Extraordinary Items & Discontinued Operations--------
Innovus Pharma Profit/ Loss (Net Income)
-6.5M-13.7M-4.2M-4.82M-3.95M-0.23M-2.25M-0.06M
Average Shares used to compute Diluted EPS157.93M94.11M------
Average Shares used to compute Basic EPS157.93M94.11M------
Income Before Nonrecurring Items-5.8M-12.43M------
Income from Nonrecurring Items-0.7M-1.27M------
Innovus Pharma Earnings Per Share Basic Net
-0.04-0.15-0.10-0.18----
Innovus Pharma Earnings Per Share Diluted Net
-0.04-0.15------
EPS Diluted Before Nonrecurring Items-0.04-0.14------
Preferred Dividends Acc Pd--------
Dividends Common--------
Dividend Per Share Common0.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Innovus Pharma stock analysis involves checking at least a few of the important things like:

  • Topline: A growing topline, as seen from the Innovus Pharma revenue chart, as is the case with Innovus Pharma indicates a growing business. One needs to compare the YoY topline or sales growth of INNV stock with its peers like CANF stock and NNVC stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-6.5M for INNV stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the INNV income statement, one can check the Innovus Pharma historical stock prices to check how the price has moved with time.

Innovus Pharma Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
1.5
Dividend Yield
0%